Additional file 4 of The efficacy and safety of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for ovarian cancer: a systematic review and meta-analysis

Authors :: Yingzhu Yang
Nannan Du
Laidi Xie
Jiang, Jing
Jiahang Mo
Jiaze Hong
Danyi Mao
Ng, Derry Minyao
Shi, Huiwei
Publication Year :: 2020
Publisher :: figshare, 2020.
Abstract: Additional file 4: Supplementary Table 1. Characteristics of included clinical trials in the meta-analysis.

Full Text Access

Tools